Cargando…
Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
PURPOSE: Identifying axial length growth rate as an indicator of fast progression before initiating atropine 0.01% for myopia progression in children. METHOD: From baseline, axial length growth over six months was measured prospectively. Subjects were then initiated on atropine 0.01% if axial length...
Autores principales: | Rose, Loreto V. T., Schulz, Angela M., Graham, Stuart L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282033/ https://www.ncbi.nlm.nih.gov/pubmed/34264970 http://dx.doi.org/10.1371/journal.pone.0254061 |
Ejemplares similares
-
Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022) -
Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022) -
Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022) -
Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023) -
Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)